Erythropoiesis-stimulating agents in heart failure: leave it or re-take it?

Eur J Heart Fail. 2015 Nov;17(11):1089-90. doi: 10.1002/ejhf.432. Epub 2015 Nov 3.

Authors

Massimo Volpe^{1

2}, Caterina Santolamazza¹, Vittoria Mastromarino¹

Affiliations

¹ Cardiology Department, Clinical and Molecular Medicine Department, Sapienza University of Rome, Rome, Italy.
² IRCCS Neuromed, Pozzilli, IS, Italy.

PMID: 26531211
DOI: 10.1002/ejhf.432

No abstract available

Publication types

Editorial
Comment

MeSH terms

Anemia / drug therapy
Erythropoiesis
Erythropoietin
Heart Failure / drug therapy*
Hematinics / therapeutic use*
Humans
Kidney Failure, Chronic / drug therapy

Substances

Hematinics
Erythropoietin